Sepsis modulates aortic AT1 and P 2 Y 6 receptors to produce vascular hyporeactivity in mice

• Published in: Journal of receptors and signal transduction 2023-12, Vol.43 (2), p.37-49
• Main Authors: Jagadeesh, T, Choudhury, Soumen, Gari, Manju, Singh, Vandana, Shukla, Amit, Garg, Satish K
• Format: Article
• Language: English
• ISSN: 1079-9893; 1532-4281
• DOI: 10.1080/10799893.2023.2204960

Hyporeactivity to vasopressors leading to multiple organ failure is a serious clinical implication in sepsis. Though the regulatory role of purinoceptors in inflammation is reported, their involvement in sepsis-induced vasoplegia is still unknown. Thus we investigated the effect of sepsis on vascular AT1 and P Y receptors. Polymicrobial sepsis was induced by cecal ligation and puncture in mice. Vascular reactivity was assessed by organ bath study and aortic mRNA expression of AT1 and P Y was quantified by qRT-PCR. Both angiotensin-II and UDP produced higher contractions in the absence of endothelium as well as following inhibition of nitric oxide synthase. Angiotensin-II mediated aortic contraction was antagonized by losartan (AT1 antagonist), but not by PD123319 (AT2 antagonist) whereas UDP-induced aortic contraction was significantly inhibited by MRS2578 (P Y antagonist). In addition, MRS2578 significantly inhibited the contractile response of Ang-II. Compared to SO mice, angiotensin-II and UDP-induced maximum contraction were found to be significantly attenuated in sepsis. Accordingly, aortic mRNA expression of AT1a receptors was significantly down-regulated while that of P Y receptors was significantly increased in sepsis. 1400 W (a selective iNOS inhibitor) significantly reversed angiotensin-II-induced vascular hyporeactivity in sepsis without affecting UDP-induced hypo-reactivity. Sepsis-induced vascular hyporeactivity to angiotensin-II is mediated by enhanced expression of iNOS. Moreover, AT1R-P Y cross talk/heterodimerization could be a novel target for regulating vascular dysfunction in sepsis.